These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20836135)

  • 1. Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients.
    Cersósimo MG; Perandones C; Micheli FE; Raina GB; Beron AM; Nasswetter G; Radrizzani M; Benarroch EE
    Mov Disord; 2011 Jan; 26(1):188-90. PubMed ID: 20836135
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia: initiators and progressors of pathology in Parkinson's disease.
    Halliday GM; Stevens CH
    Mov Disord; 2011 Jan; 26(1):6-17. PubMed ID: 21322014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein in salivary gland as biomarker for Parkinson's disease.
    Campo F; Carletti R; Fusconi M; Pellicano C; Pontieri FE; Di Gioia CR; de Vincentiis M
    Rev Neurosci; 2019 Jul; 30(5):455-462. PubMed ID: 30471223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.
    Kazantsev AG; Kolchinsky AM
    Arch Neurol; 2008 Dec; 65(12):1577-81. PubMed ID: 19064744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological lesions in colonic biopsies during Parkinson's disease.
    Lebouvier T; Chaumette T; Damier P; Coron E; Touchefeu Y; Vrignaud S; Naveilhan P; Galmiche JP; Bruley des Varannes S; Derkinderen P; Neunlist M
    Gut; 2008 Dec; 57(12):1741-3. PubMed ID: 19022934
    [No Abstract]   [Full Text] [Related]  

  • 10. Nigral burden of alpha-synuclein correlates with striatal dopamine deficit.
    Kovacs GG; Milenkovic IJ; Preusser M; Budka H
    Mov Disord; 2008 Aug; 23(11):1608-12. PubMed ID: 18649394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
    Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
    Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
    Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
    Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.
    Miki Y; Tomiyama M; Ueno T; Haga R; Nishijima H; Suzuki C; Mori F; Kaimori M; Baba M; Wakabayashi K
    Neurosci Lett; 2010 Jan; 469(3):357-9. PubMed ID: 20026177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of immunoreactive transforming growth factor-alpha in non-neoplastic human salivary glands.
    Ogbureke KU; MacDaniel RK; Jacob RS; Durban EM
    Histol Histopathol; 1995 Jul; 10(3):691-6. PubMed ID: 7579819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
    Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
    Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of alpha-synuclein and tau genotypes in Parkinson's disease.
    Mamah CE; Lesnick TG; Lincoln SJ; Strain KJ; de Andrade M; Bower JH; Ahlskog JE; Rocca WA; Farrer MJ; Maraganore DM
    Ann Neurol; 2005 Mar; 57(3):439-43. PubMed ID: 15732111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease.
    Langston JW; Sastry S; Chan P; Forno LS; Bolin LM; Di Monte DA
    Exp Neurol; 1998 Dec; 154(2):684-90. PubMed ID: 9878203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated α-synuclein immunoreactivity in nerve fibers from minor salivary glands in Parkinson's disease.
    Carletti R; Campo F; Fusconi M; Pellicano C; De Vincentiis M; Pontieri FE; Di Gioia CR
    Parkinsonism Relat Disord; 2017 May; 38():99-101. PubMed ID: 28259622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.